Codes / ICD10CM / T48.6X5A

T48.6X5A Adverse effect of antiasthmatics, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of antiasthmatics, initial encounter

Summary

This condition represents an adverse reaction to antiasthmatic medications during the initial encounter. Antiasthmatics are used to manage respiratory conditions like asthma or COPD, and adverse effects can occur due to individual sensitivity, drug interactions, or dosing issues. The initial encounter specifies the first time the patient seeks care for this reaction.

Causes

Adverse effects may result from unintended reactions to antiasthmatic medications, such as inhalers, nebulizers, or oral formulations. These can stem from individual patient factors, drug interactions, or incorrect administration. Therapeutic errors, like dosing mistakes or device misuse, may also contribute to the reaction.

Risk Factors

  • Use of medications with narrow therapeutic windows (e.g., long-acting beta-agonists, theophylline).
  • Lack of proper storage or labeling of medications.
  • History of substance misuse or accidental exposure in vulnerable populations.
  • Concurrent use of multiple drugs with overlapping respiratory effects.
  • Renal or hepatic impairment affecting drug metabolism.

Symptoms

  • Excessive bronchodilation (e.g., tachycardia, tremors, palpitations).
  • Nausea, vomiting, or gastrointestinal distress.
  • Dizziness, headache, or altered mental status.
  • Worsening respiratory symptoms or paradoxical bronchospasm.

Diagnosis

Diagnosis involves evaluating the patient's medication history, clinical presentation, and timing of symptoms relative to antiasthmatic use. Healthcare providers assess for signs of adverse reactions, rule out other causes, and confirm the link to the medication. Laboratory tests or imaging may be used to exclude other conditions.

Treatment Options

Treatment focuses on managing symptoms and discontinuing the offending medication. Supportive care, such as monitoring vital signs or administering antidotes (if applicable), may be necessary. Adjustments to the treatment plan, including switching to alternative medications, are common.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and timely intervention. Most patients recover with appropriate management, but follow-up is essential to monitor for recurrence or complications. Ongoing assessment of medication tolerance and patient education on proper use are key.

Complications

Complications can include severe cardiovascular effects (e.g., arrhythmias), respiratory distress, or systemic toxicity. In rare cases, prolonged exposure may lead to organ damage or life-threatening reactions requiring intensive care.

Lifestyle & Prevention

  • Store medications securely to prevent accidental exposure.
  • Follow dosing instructions carefully and avoid self-adjusting doses.
  • Inform healthcare providers of all medications, including over-the-counter drugs.
  • Use proper inhaler or nebulizer techniques to ensure effective delivery.

When to Seek Professional Help

Seek immediate medical attention if experiencing severe symptoms like chest pain, difficulty breathing, or altered consciousness. Contact a provider for persistent or worsening reactions, even if mild.

Tips for Medical Coders

Document the specific antiasthmatic involved, the nature of the adverse effect, and the encounter type (initial). Ensure clinical details support the diagnosis and align with the code's definition. Include any relevant patient history or contributing factors to justify the code assignment.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

T48.6X5A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.